Skip to main content

Table 2 Reported side effects (total number = 475)

From: Acceptance and tolerability of an adjuvanted nH1N1 vaccine in HIV-infected patients in the Cologne-Bonn cohort

 

Occurrence

Mean duration

Mean severity

Grade of Severity

    

1

2

3

4

 

N (%)

Days (SD)

(*)

N (%)

N (%)

N (%)

N (%)

       

Local symptoms

Pain

285 (60%)

2.9 (± 1,1)

1.4 (± 0.5)

200 (42%)

69 (15%)

16 (3%)

0 (0%)

Swelling

95 (20%)

2.6 (± 1.3)

14.8 (± 17.1) †

Redness

52 (11%)

3.1 (± 1.5)

14.8 (± 17.1) †

       

Systemic symptoms

Fever

47 (10%)

2.0 (± 1.0)

1.2 (± 0.3)

41 (9%)

6 (1%)

1 (0%)

0 (0%)

Muscle/jointache

172 (36%)

2.7 (± 1.3)

1.4 (± 0.5)

121 (25%)

38(8%)

14 (3%)

0 (0%)

Headache

126 (27%)

2.5 (± 1.5)

1.4 (± 0.6)

93 (20%)

21 (4%)

13 (3%)

0 (0%)

Fatigue

207 (44%)

2.8 (± 1.5)

1.5 (± 0.6)

125 (26%)

65 (14%)

20(4%)

0 (0%)

  1. SD Standard deviation
  2. (*) Severity: from 1 (mild) to 4 (life threatening), according to CTCAE v4.0 criteria (except severity of "swelling" and "redness", see below)
  3. † Severity of "swelling" and "redness": mean diameter (standard deviation) in millimeters
  4. ✤ no grading system was used